Hypertension – from diagnosis to therapy .Part II – therapy of hypertension

Ewa Chlebda; Monika Skrzypiec-Spring; Dominika Skrzypiec; Anna Merwid-Ląd; Małgorzata Trocha; Barbara Szumska; Adam Szeląg

Abstract

5/2005 vol. 8

Hypertension – from diagnosis to therapy .Part II – therapy of hypertension

Ewa Chlebda

,

Monika Skrzypiec-Spring

,

Dominika Skrzypiec

,

Anna Merwid-Ląd

,

Małgorzata Trocha

,

Barbara Szumska

,

Adam Szeląg

Przew Lek 2005; 5: 84-99

Online publish date: 2005/07/15

View full text

AMA

Chlebda E, Skrzypiec-Spring M, Skrzypiec D, et al. Hypertension – from diagnosis to therapy .Part II – therapy of hypertension. Przewodnik Lekarza/Guide for GPs. 2005:84-99.

APA

Chlebda, E., Skrzypiec-Spring, M., Skrzypiec, D., Merwid-Ląd, A., Trocha, M., & Szumska, B. et al. (2005). Hypertension – from diagnosis to therapy .Part II – therapy of hypertension. Przewodnik Lekarza/Guide for GPs, 84-99.

Chicago

Chlebda, Ewa, Monika Skrzypiec-Spring, Dominika Skrzypiec, Anna Merwid-Ląd, Małgorzata Trocha, Barbara Szumska, and Adam Szeląg. 2005. "Hypertension – from diagnosis to therapy .Part II – therapy of hypertension". Przewodnik Lekarza/Guide for GPs: 84-99.

Harvard

Chlebda, E., Skrzypiec-Spring, M., Skrzypiec, D., Merwid-Ląd, A., Trocha, M., Szumska, B., and Szeląg, A. (2005). Hypertension – from diagnosis to therapy .Part II – therapy of hypertension. Przewodnik Lekarza/Guide for GPs, pp.84-99.

MLA

Chlebda, Ewa et al. "Hypertension – from diagnosis to therapy .Part II – therapy of hypertension." Przewodnik Lekarza/Guide for GPs, 2005, pp. 84-99.

Vancouver

Chlebda E, Skrzypiec-Spring M, Skrzypiec D, Merwid-Ląd A, Trocha M, Szumska B et al. Hypertension – from diagnosis to therapy .Part II – therapy of hypertension. Przewodnik Lekarza/Guide for GPs. 2005:84-99.

Hypertension management includes both non pharmacological and pharmacological treatment. There are 7 main groups of hypertension drugs: diuretics, β-adrenergic antagonists, α-adrenergic antagonist, a- and β-adrenergic antagonists, calcium channel antagonists, angiotensin converting enzyme inhibitors and angiotensin II receptor blockers. According to European Society of Hypertension, European Society of Cardiology and Polish Society of Cardiology and Polish Society of Hypertension the potential of all these groups of drugs to lower blood pressure is comparable. The factors which can influence the choice of the certain group of drugs include coexisting diseases, drug tolerance and drug interactions.

Keywords

hypertension, therapy of hypertension

Integrated with